期刊文献+

益气化浊法治疗气虚痰浊型单纯收缩期高血压临床研究 被引量:6

Clinical Study on Treatment of Isolated Systolic Hypertension of Qi Deficiency and Phlegm Turbidity with Qi-tonifying and Turbidity-resolving Method
暂未订购
导出
摘要 目的:观察益气化浊法治疗气虚痰浊型单纯收缩期高血压(ISH)的临床疗效。方法:将62例气虚痰浊型ISH患者随机分为治疗组32例和对照组30例,其中治疗组予复方芪麻胶囊口服,日3次,每次2粒;对照组予苯磺酸氨氯地平(络活喜)口服,日1次,每次5 mg,必要时加用吲哒帕胺缓释片(纳催离),日1次,每次1.5 mg,调整使用至血压达标并维持稳定,8周为1个疗程。观察治疗前后中医证候疗效、血压平滑指数变化情况。结果:治疗组有效率为93.4%,对照组有效率为70.0%,两组疗效比较有显著性差异(P<0.05);治疗后两组血压平滑指数比较,治疗组优于对照组(P<0.05)。结论:复方芪麻胶囊能有效改善气虚痰浊型ISH患者的临床症状,且降压作用平稳。 Objective : To observe the clinic effect of qi-tonifying and turhidity-resolving method in the treatment of isolated systolic hypertension with qi deficiency and phlegm turbidity. Methods: 62 ISH patients with qi deficiency and phlegm turbidity were randomized into treatment group (32 cases) and control group (30 cases). The treatment group received Compound Qima Capsules ( CQC), 3 times daily, 2 capsules each time;while the control group received Amlodipine Tablets. 1 time a day, 5mg each time. When needed, Indapamide sustained release tablets were given, 1 time a day, I. 5 mg, to adjust blood pressure and main- tain the stability. The course was 8 weeks. The change of TCM symptoms and smoothness indexes were observed before and after the treatment. Resuhs : The general effective rate was 93.4% in the treatment group, while it was 70.0% in control group. The significant differences existed between the two groups ( P 〈 0.05 ). The treatment group was hetter than the control group ( P 〈 0.05 ) in smooth index after the treatment. Conclusion: Compound Qima Capsules can effectively improve the symptoms of ISH patients with qi deficiency and phlegm turbidity, with evident effect of lowing blood pressure.
出处 《河南中医》 2012年第11期1459-1460,共2页 Henan Traditional Chinese Medicine
基金 广东省科技攻关项目(编号:2010A030100007)
关键词 益气化浊法 气虚痰浊证 复方芪麻胶囊 单纯收缩期高血压 qi-tonifying and turbidity-resolving method syndrome of qi deficiency and phlegm turbidity Compound Qima Capsules isolated systolic hypertension
  • 相关文献

参考文献4

二级参考文献14

  • 1李小鹰.2010版《中国高血压防治指南》解读——新指南,新在哪里?[J].中国医学前沿杂志(电子版),2011,3(3):67-68. 被引量:15
  • 2SHEP Cooperative Research Group.Prevention of by antihypertensive drug treatment in older persons with isolated systolic hypertension:Final reasults of the systolic Hypertension in the Elderly program.JAMA,1991,256:3255-3264.
  • 3Mitchell GF,Pfeffer MA.Pulsatile hemodynamics in hypertension.Curr Opin Cardiol,1999,14:361-369.
  • 4Amery A,Birkenhager W,Brixko P,et al.Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial.Lancet,1985,1:349-1354.
  • 5Staessen JA,Fagard R,Thijs L,et al.Randomized double-blind comparison of pllacebo and active treatment for older patients with isolated systolic hypertension.Lancet,1997,350:757-764.
  • 6Wang JG,Staessen JA,Gong L,et al.Chinese trial on isolated systolic hypertension in the elderly.Systolic Hypertension in China (Syst -China) Collaborative Group.Archives of Internal Medicine,2000,160(2):211-220.
  • 7Safar ME.Systolic blood pressure,pulse pressure and arterial stiffness as cardiovascular risk factors.Current Opinion in Nephrology &Hypertension,2001,10(2):257-261.
  • 8中华人民共和国卫生部.中药新药临床研究指导原则·第1辑【S】.,1993.28-31.
  • 9中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版).高血压杂志,2005,134:2-2.
  • 10胡大一.遵循《中国高血压防治指南》(2009年基层版)的社会实践意义[J].中华高血压杂志,2010,18(1):9-10. 被引量:26

共引文献125

同被引文献68

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部